Lymphocyte-activating gene 3 expression in tumor cells predicts immune checkpoint inhibitor response in triple negative breast cancer

INTRODUCTION: Immune checkpoint inhibitor (ICI) is one of the standard treatment strategies in triple negative breast cancer (TNBC). However, the benefit of ICI with chemotherapy is limited in metastatic TNBC. In this study, we evaluated the effect of PD-L1 and LAG-3 expression on tissue microenviro...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ji-Yeon, Kim, Jeehyun, Cho, Eun Yoon, Park, Yeon Hee, Ahn, Jin Seok, Kim, Kyoung-Mee, Im, Young-Hyuck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060989/
https://www.ncbi.nlm.nih.gov/pubmed/37007114
http://dx.doi.org/10.3389/fonc.2023.1146934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060989/
https://www.ncbi.nlm.nih.gov/pubmed/37007114
http://dx.doi.org/10.3389/fonc.2023.1146934

Ejemplares similares